Diabetic Coma

Diabetic coma or diabetic ketoacidosis – (DKA) occurs when a diabetic does not properly balance their insulin intake with their diet or activity.
What is a Diabetic Coma?

Diabetic coma is a rare but serious occurrence. It is important to be aware of the risks of coma in diabetic patients and the possible causes.

Read More

Overview

Feature Articles

Latest Diabetic Coma News and Research

Study provides a rare view of real-world use of off-label drugs prescribed for Type 1 diabetes

Study provides a rare view of real-world use of off-label drugs prescribed for Type 1 diabetes

FDA approves first-ever type 1 diabetes delaying drug Tzield (teplizumab-mzwv)

FDA approves first-ever type 1 diabetes delaying drug Tzield (teplizumab-mzwv)

Study: Youth with type1 diabetes who use insulin pumps less likely to develop diabetic retinopathy

Study: Youth with type1 diabetes who use insulin pumps less likely to develop diabetic retinopathy

Study could offer a new way to treat Type 1 and Type 2 diabetes

Study could offer a new way to treat Type 1 and Type 2 diabetes

Tattoo sensor: A needleless glucose monitor for diabetes patients

Tattoo sensor: A needleless glucose monitor for diabetes patients

Treatment outcomes in type 1 diabetes could be improved across all age groups

Treatment outcomes in type 1 diabetes could be improved across all age groups

New data supports use DAAs in patients with HCV recurrence following liver transplantation

New data supports use DAAs in patients with HCV recurrence following liver transplantation

Study explains why generic insulin remains out of reach for diabetes patients

Study explains why generic insulin remains out of reach for diabetes patients

State highlights: Battle over jail medical care in Texas jails; Medicaid coverage for inmates; N.C. docs sue over Medicaid billing system

State highlights: Battle over jail medical care in Texas jails; Medicaid coverage for inmates; N.C. docs sue over Medicaid billing system

WHO welcomes forthcoming agreement to improve health care access

WHO welcomes forthcoming agreement to improve health care access

Researchers develop smartwatches to uncover reasons behind sleeping problems

Researchers develop smartwatches to uncover reasons behind sleeping problems

Researchers develop new method for continuous glucose monitoring in patients with type 1 diabetes

Researchers develop new method for continuous glucose monitoring in patients with type 1 diabetes

Longer looks: 'Bad suga' damages a neighborhood; A nurse's dying gift; Are ethical guidelines impeding patient care?

Longer looks: 'Bad suga' damages a neighborhood; A nurse's dying gift; Are ethical guidelines impeding patient care?

Elimination of glucagon action may help convert Type 1 diabetes into non-insulin-dependent disorder

Elimination of glucagon action may help convert Type 1 diabetes into non-insulin-dependent disorder

UT Southwestern initiates study on hormone leptin for people with type 1 diabetes

UT Southwestern initiates study on hormone leptin for people with type 1 diabetes

First US forum gathers doctors and children who no longer need insulin

First US forum gathers doctors and children who no longer need insulin

New study shows leptin treatment may help reduce type 1 diabetes

New study shows leptin treatment may help reduce type 1 diabetes

Genetic factors play an important role in the development of type 1 diabetes

Genetic factors play an important role in the development of type 1 diabetes

Type 1 diabetes patients sought for UT Southwestern clinical drug trial

Type 1 diabetes patients sought for UT Southwestern clinical drug trial

Leptin shows potential for type 1 diabetes

Leptin shows potential for type 1 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.